Published online May 2, 2005
PEDIATRICS Vol. 115 No. 5 May 2005, pp. 1299-1306 (doi:10.1542/10.1542/peds.2004-1680)
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Web of Science (4)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Widness, J. A.
Right arrow Articles by Stevenson, D. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Widness, J. A.
Right arrow Articles by Stevenson, D. K.
Related Collections
Right arrow Blood
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Reduction in Red Blood Cell Transfusions Among Preterm Infants: Results of a Randomized Trial With an In-Line Blood Gas and Chemistry Monitor

John A. Widness, MD*, Ashima Madan, MD{ddagger}, Ligia A. Grindeanu, MD*, M. Bridget Zimmerman, PhD§, David K. Wong, PhD|| and David K. Stevenson, MD{ddagger}

* Department of Pediatrics, College of Medicine
§ Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa
{ddagger} Department of Pediatrics, Stanford University School of Medicine, Stanford, California
|| Independent consultant, Del Mar, California

Background. Critically ill, extremely premature infants develop anemia because of intensive laboratory blood testing and undergo multiple red blood cell (RBC) transfusions in the early weeks of life. To date, researchers have had only limited success in finding ways to reduce transfusions significantly in this patient population.

Objective. To reduce RBC transfusions for these infants by using a point-of-care bedside monitor that returns analyzed blood to the patient.

Design, Setting, and Patients. This was a prospective, 2-center, randomized, open, controlled, clinical trial with a 1:1 assignment of extremely low birth weight infants (weighing 500–1000 g at birth) to control or monitor groups and analysis with the intention-to-treat approach. Predefined RBC transfusion criteria were applied uniformly in the 2 groups.

Interventions. Clinical treatment of study subjects with an in-line, ex vivo, bedside monitor that withdraws blood through an umbilical artery catheter, analyzes blood gases and sodium, potassium, and hematocrit levels, and returns the sample to the patient.

Main Outcome Measures. The total volume and number of RBC transfusions during the first 2 weeks of life and the total volume of blood removed for laboratory testing.

Results. The trial was terminated prematurely when one center's NICU changed its standard method of laboratory testing. In the first 2 weeks of life, there was a nonsignificant 17% lower cumulative RBC transfusion volume in the monitor group (n = 46), compared with the control group (n = 47). However, data from the first week only (the period of greater catheter use) demonstrated a significant 33% lower cumulative RBC transfusion volume in the monitor group. Cumulative phlebotomy loss was ~25% less in the monitor group throughout the 2-week study period. There was no difference between groups in neonatal mortality, morbidity, and neurodevelopmental outcome rates at 18 to 24 months. This is the first randomized trial documenting that RBC transfusions administered to neonates can by reduced by decreasing laboratory phlebotomy loss.

Conclusions. As long as an umbilical artery catheter is available for blood sampling with an in-line blood gas and chemistry monitor, significant reductions in neonatal RBC transfusions can be achieved. The patients most likely to benefit from monitor use are the smallest, most critically ill newborns.

Key Words: point-of-care monitor • red blood cell transfusions

Abbreviations: ELBW, extremely low birth weight • RBC, red blood cell • UAC, umbilical artery catheter • POC, point-of-care

Accepted Sep 21, 2004.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 NeoReviewsHome page
J. A. Widness
Pathophysiology of Anemia During the Neonatal Period, Including Anemia of Prematurity
NeoReviews, November 1, 2008; 9(11): e520 - e525.
[Abstract] [Full Text] [PDF]

Home page
 NeoReviewsHome page
J. A. Widness
Treatment and Prevention of Neonatal Anemia
NeoReviews, November 1, 2008; 9(11): e526 - e533.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
E F Bell
When to transfuse preterm babies
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2008; 93(6): F469 - F473.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
L. E Hinds, C. L Brown, and S. J Clark
Point of care estimation of haemoglobin in neonates
Arch. Dis. Child. Fetal Neonatal Ed., September 1, 2007; 92(5): F378 - F380.
[Abstract] [Full Text] [PDF]